Journal article
Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations
Abstract
OBJECTIVES: The objective of this review was to examine the latest literature regarding the effectiveness of monoclonal antibodies as COVID-19 prophylaxis therapy for immunocompromised patient populations.
METHODS: Literature review of published real-world and randomized control trials (RCTs) from 2020 to May 2023.
Authors
Cowan J; Amson A; Christofides A; Chagla Z
Journal
International Journal of Infectious Diseases, Vol. 134, , pp. 228–238
Publisher
Elsevier
Publication Date
September 2023
DOI
10.1016/j.ijid.2023.06.021
ISSN
1201-9712